Cleveland BioLabs Inc. (NASDAQ:CBLI) went up by 5.05% during the previous trading session, and it is maintaining the win ahead of Tuesday’s trading session. The share price of the Biotechnology giant went up by $2.29 to trade ended Tuesday trading at $2.18. This is up from the $2.18 price recorded on Monday’s trading session. Thanks to this latest performance, CBLI is closer to the higher price 52-week target of $40.00 and further from the lowest price target of $40.00. Its performance from the start of the year has also been positive, with CBLI up by 280.40% year-to-date.
Cleveland BioLabs Inc. (CBLI) started the day trading at $2.19 and recorded an intraday high of $2.42. It also recorded an intraday low of $2.1692 during Tuesday’s trading session. Cleveland BioLabs Inc. is a very active stock that recorded a trading volume that is less than -154.93% of the average daily trading volume on Tuesday. The stock’s trading volume on Tuesday was 502098, which is less than -154.93 of the total average daily trading volume of 1.28 million.
Cleveland BioLabs Inc. (NASDAQ:CBLI) 2020 Performance Impressive
The increase in CBLI’s stock price on Tuesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of CBLI currently stands at $5.00, which is higher than the current trading price of the stock by 54.2%. However, CBLI’s current trading price is -358.0% lower than the 52-week low price of $0.50. In terms of trading volume, Cleveland BioLabs Inc. currently experienced healthy participation during the last trading session. 502098 shares of Cleveland BioLabs Inc. were traded on the stock exchange on Tuesday, which is less than -154.93% of the 1.28 million average trading volume of the stock.
The performance of the stock has been positive over the past year. CBLI’s performance over the past one year has seen it surge by 52.67%, while the stock has gone up by 301.61% in the last six months. The quarterly performance of CBLI currently stands at 41.36%, and it is up by 49.67% in the last month. The only negative figure was from the weekly performance, which currently reads -6.53%. At the time of writing CBLI’s report, the company has a total market cap of $29.54M, making it one of the largest publicly-traded companies in the world.Cleveland BioLabs Inc. also has over 7 employees all over the world.
CBLI Insider Activities
For Cleveland BioLabs Inc., insiders hold 3.20% of all company shares. The insider transactions over the past six months are down by 0.00%. After these transactions, insiders at Cleveland BioLabs Inc. now hold 7.34M shares, which is over 3.68% of the total company stocks. Institutional investors currently hold a large chunk of the CBLI shares, as they control 64.39% of the company’s total stock.
CBLI Fundamental Analysis
For Cleveland BioLabs Inc., the stock’s diluted earnings per share (EPS) stands at -0.21. The stock’s EPS growth this year is 26.70%, -19.00% in the previous five years. In terms the average annual revenue of -19.00% over the past half a decade.
The Return on Investment (ROI) on Cleveland BioLabs Inc.’s stock currently stands at 52.50%.
CBLI Analysts Prediction
Analysts at WBB Securities believe that CBLI is Hold, and they have a price target of between $6.50 and $6.50. CBLI received a positive rating from Rodman & Renshaw, which set a price target of $8-$11 for the stock.
CBLI Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of CBLI currently stands at 17.98%, while the SMA50 is 21.30%. The biggest one is the SMA200, which is currently reading 51.32% ahead of Tuesday’s trading session. The Relative Strength Index of this stock is 53.48.
